Bridging the Gap: Improving Clinical Development and the Regulatory Pathways for Health Products for Neglected Diseases

Thomas J. Bollyky

Working Papers from eSocialSciences

Abstract: There has been tremendous progress over the last decade in the development of health products for neglected diseases. These include drugs, vaccines, and diagnostics for malaria and tuberculosis, which kill millions of people annually, plus other diseases like changes and dengue fever, which may less familiar, but nonetheless exact a large and often lethal toll in the world’s poorest communities. Led by product development public- private partnerships (PDPs) and fueled by the support of the Bill & Melinda Gates Foundation, the National Institutes of Health, and other donors, there are now dozens of candidate products in the pipeline. [Working Paper No. 217]

Keywords: health products; drugs; vaccines; malaria; tuberculosis; dengue fever; development public- private partnerships; Bill & Melinda Gates Foundation; National Institutes of Health (search for similar items in EconPapers)
Date: 2010-07
New Economics Papers: this item is included in nep-hea
Note: Institutional Papers
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://www.esocialsciences.org/Download/repecDownl ... &AId=2640&fref=repec

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ess:wpaper:id:2640

Access Statistics for this paper

More papers in Working Papers from eSocialSciences
Bibliographic data for series maintained by Padma Prakash ().